ResMed Inc. (BMV:RMD)

Market Cap	713.13B
Revenue (ttm)	102.63B
Net Income (ttm)	26.84B
Shares Out	n/a
EPS (ttm)	182.11
PE Ratio	26.57
Forward PE	24.27
Dividend	41.98 (0.88%)
Ex-Dividend Date	May 8, 2025

Volume	n/a
Average Volume	6
Open	4,745.00
Previous Close	4,745.00
Day's Range	4,745.00 - 4,745.00
52-Week Range	3,040.00 - 5,111.00
Beta	n/a
RSI	74.68
Earnings Date	Aug 1, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1989
• Employees: 9,980
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: RMD

Financial Performance

In 2024, ResMed's revenue was $4.69 billion, an increase of 10.95% compared to the previous year's $4.22 billion. Earnings were $1.02 billion, an increase of 13.75%.

Financial numbers in USD